Effect of long-term selenium yeast intervention on activity and gene expression of antioxidant and xenobiotic metabolising enzymes in healthy elderly volunteers from the Danish Prevention of Cancer by Intervention by Selenium (PRECISE) Pilot Study

British Journal of Nutrition

Volumn 99, Issue 6, 2008, Pages 1190-1198

  Ravn Haren, Gitte ^a   Krath, Britta N ^a   Overvad, Kim ^b   Cold, Søren ^c   Moesgaard, Sven ^d   Larsen, Erik H ^a   Dragsted, Lars O ^a  

^a TECHNICAL UNIVERSITY OF DENMARK   (Denmark)

^b AALBORG UNIVERSITY HOSPITAL   (Denmark)

^c ODENSE UNIVERSITY HOSPITAL   (Denmark)

^d Pharma Nord ApS   (Denmark)

Author keywords

Electrophile response elements; Human nutrition; Oxidative defence; Selenium

Indexed keywords

ANTIOXIDANT; AROMATIC HYDROCARBON RECEPTOR; COMPLEMENTARY DNA; GLUTAMATE CYSTEINE LIGASE; GLUTATHIONE PEROXIDASE; GLUTATHIONE PEROXIDASE 1; GLUTATHIONE REDUCTASE; GLUTATHIONE TRANSFERASE; MULTIVITAMIN; PLACEBO; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE (PHOSPHATE) DEHYDROGENASE (QUINONE); RNA; SELENIUM; SELENOPRECISE; TRANSCRIPTION FACTOR AP 1; TRANSCRIPTION FACTOR FRA 1; UNCLASSIFIED DRUG; VITAMIN; XENOBIOTIC AGENT;

ADULT; AGED; ARTICLE; BLOOD SAMPLING; CANCER RISK; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DNA SYNTHESIS; DOUBLE BLIND PROCEDURE; DOWN REGULATION; DRUG DOSE COMPARISON; DRUG EFFECT; ENZYME ACTIVITY; ERYTHROCYTE; FEMALE; GENE EXPRESSION; HUMAN; HUMAN EXPERIMENT; LEUKOCYTE; MALE; NORMAL HUMAN; NUCLEOTIDE SEQUENCE; RANDOMIZED CONTROLLED TRIAL; RNA ISOLATION; SMOKING; THROMBOCYTE; VITAMIN SUPPLEMENTATION; VOLUNTEER; BLOOD; DENMARK; DIET SUPPLEMENTATION; DNA PROBE; ENZYMOLOGY; GENETICS; METABOLISM; MOLECULAR GENETICS; NEOPLASM; PILOT STUDY; SEX DIFFERENCE; YEAST;

AGED; ANTIOXIDANTS; BASE SEQUENCE; BLOOD PLATELETS; DENMARK; DIETARY SUPPLEMENTS; DNA PROBES; DOUBLE-BLIND METHOD; ERYTHROCYTES; FEMALE; GENE EXPRESSION; GLUTATHIONE PEROXIDASE; GLUTATHIONE REDUCTASE; GLUTATHIONE TRANSFERASE; HUMANS; MALE; MOLECULAR SEQUENCE DATA; NEOPLASMS; PILOT PROJECTS; SELENIUM; SEX FACTORS; XENOBIOTICS; YEAST, DRIED;

EID: 45549103815     PISSN: 00071145     EISSN: 14752662     Source Type: Journal    
DOI: 10.1017/S0007114507882948     Document Type: Article

References (39)

1. Clark LC, Combs GF Jr, Turnbull BW, et al. (1996) Effects of selenium supplementation for cancer prevention in patients with carcinoma of the skin. A randomized controlled trial. Nutritional Prevention of Cancer Study Group. JAMA 276, 1957-1963.
2. Clark LC, Dalkin B, Krongrad A, et al. (1998) Decreased incidence of prostate cancer with selenium supplementation: Results of a double-blind cancer prevention trial. Br J Urol 81, 730-734.
3. Duffield-Lillico AJ, Slate EH, Reid ME, et al. (2003) Selenium supplementation and secondary prevention of nonmelanoma skin cancer in a randomized trial. J Natl Cancer Inst 95, 1477-1481.
4. Duffield-Lillico AJ, Reid ME, Turnbull BW, Combs GF Jr, Slate EH, Fischbach LA, Marshall JR & Clark LC (2002) Baseline characteristics and the effect of selenium supplementation on cancer incidence in a randomized clinical trial: A summary report of the Nutritional Prevention of Cancer Trial. Cancer Epidemiol Biomarkers Prev 11 630-639.
5. Combs GF Jr & Gray WP (1998) Chemopreventive agents: Selenium. Pharmacol Ther 79, 179-192.
6. Whanger PD (2004) Selenium and its relationship to cancer: An update. Br J Nutr 91, 11-28.
7. El-Bayoumy K & Sinha R (2005) Molecular chemoprevention by selenium: A genomic approach. Mutat Res 591, 224-236.
8. Rao L, Puschner B & Prolla TA (2001) Gene expression profiling of low selenium status in the mouse intestine: Transcriptional activation of genes linked to DNA damage, cell cycle control and oxidative stress. J Nutr 131, 3175-3181.
9. El-Bayoumy K, Richie JP Jr, Boyiri T, Komninou D, Prokopczyk B, Trushin N, Kleinman W, Cox J, Pittman B & Colosimo S (2002) Influence of selenium-enriched yeast supplementation on biomarkers of oxidative damage and hormone status in healthy adult males: A clinical pilot study. Cancer Epidemiol Biomarkers Prev 11, 1459-1465.
10. Gipp JJ, Chang C & Mulcahy RT (1992) Cloning and nucleotide sequence of a full-length cDNA for human liver γ-glutamylcysteine synthetase. Biochem Biophys Res Commun 185, 29-35.
11. Gipp JJ, Bailey HH & Mulcahy RT (1995) Cloning and sequencing of the cDNA for the light subunit of human liver γ-glutamylcysteine synthetase and relative mRNA levels for heavy and light subunits in human normal tissues. Biochem Biophys Res Commun 206, 584-589.
12. Chen C & Kong AN (2004) Dietary chemopreventive compounds and ARE/EpRE signaling. Free Radic Biol Med 36, 1505-1516.
13. Yoshioka K, Deng T, Cavigelli M & Karin M (1995) Antitumor promotion by phenolic antioxidants: Inhibition of AP-1 activity through induction of Fra expression. Proc Natl Acad Sci U S A 92, 4972-4976.
14. Venugopal R & Jaiswal AK (1996) Nrf1 and Nrf2 positively and c-Fos and Fra1 negatively regulate the human antioxidant response element-mediated expression of NAD(P)H:qUinone oxidoreductase1 gene. Proc Natl Acad Sci U S A 93, 14960-14965.
15. Jardine H, MacNee W, Donaldson K & Rahman I (2002) Molecular mechanism of transforming growth factor (TGF)-β1-induced glutathione depletion in alveolar epithelial cells. Involvement of AP-1/ARE and Fra-1. J Biol Chem 277, 21158-21166.
16. Li Y & Jaiswal AK (1992) Regulation of human NAD(P)H:qUinone oxidoreductase gene. Role of AP1 binding site contained within human antioxidant response element. J Biol Chem 267, 15097-15104.
17. Mulcahy RT & Gipp JJ (1995) Identification of a putative antioxidant response element in the 5′-flanking region of the human γ-glutamylcysteine synthetase heavy subunit gene. Biochem Biophys Res Commun 209, 227-233.
18. Reiter R & Wendel A (1984) Selenium and drug metabolism - II. Independence of glutathione peroxidase and reversibility of hepatic enzyme modulations in deficient mice. Biochem Pharmacol 33, 1923-1928.
19. Mimura J, Ema M, Sogawa K & Fujii-Kuriyama Y (1999) Identification of a novel mechanism of regulation of Ah (dioxin) receptor function. Genes Dev 13, 20-25.
20. Cauchi S, Stucker I, Cenee S, Kremers P, Beaune P & Massaad-Massade L (2003) Structure and polymorphisms of human aryl hydrocarbon receptor repressor (AhRR) gene in a French population: Relationship with CYP1A1 inducibility and lung cancer. Pharmacogenetics 13, 339-347.
21. Rayman MP (2000) The importance of selenium to human health. Lancet 356, 233-241.
22. Lyhne N, Christensen T, Groth MV, Fagt S, Biltoft-Jensen A, Hartkopp H, Hinsch H-J, Matthiessen J, Møller A, Saxholt E & Trolle E (2005) Danskernes Kostvaner 2000-2002. Hovedresultater (Dietary Habits in Denmark 2000-2002. Main Results). Søborg, Denmark: Danish Institute for Food and Veterinary Research.
23. Larsen EH, Hansen M, Paulin H, Moesgaard S, Reid M & Rayman M (2004) Speciation and bioavailability of selenium in yeast-based intervention agents used in cancer chemoprevention studies. J AOAC Int 87 225-232.
24. Sloth JJ, Larsen EH, Bugel SH & Moesgaard S (2003) Determination of total selenium and Se 77 in isotopically enriched human samples by ICP-dynamic reaction cell-MS. JAAS 18, 317-322.
25. Wheeler CR, Salzman JA, Elsayed NM, Omaye ST & Korte DW Jr (1990) Automated assays for superoxide dismutase, catalase, glutathione peroxidase, and glutathione reductase activity. Anal Biochem 184, 193-199.
26. Dragsted LO, Pedersen A, Hermetter A, Basu S, Hansen M, Haren GR, Kall M, Breinholt V, Castenmiller JJ, Stagsted J, Jacobsen J, Skibsted L, Rasmussen SE, Loft S & Sandström B (2004) The 6-a-day study: Effects of fruit and vegetables on markers of oxidative stress and antioxidative defense in healthy nonsmokers. Am J Clin Nutr 79, 1060-1072.
27. Alfthan G, Aro A, Arvilommi H & Huttunen JK (1991) Selenium metabolism and platelet glutathione peroxidase activity in healthy Finnish men: effects of selenium yeast, selenite, and selenate. Am J Clin Nutr 53, 120-125.
28. Thomson CD, Robinson MF, Butler JA & Whanger PD (1993) Long-term supplementation with selenate and selenomethionine: Selenium and glutathione peroxidase (EC 1.11.1.9) in blood components of New Zealand women. Br J Nutr 69, 577-588.
29. Levander OA, Alfthan G, Arvilommi H, Gref CG, Huttunen JK, Kataja M, Koivistoinen P & Pikkarainen J (1983) Bioavailability of selenium to Finnish men as assessed by platelet glutathione peroxidase activity and other blood parameters. Am J Clin Nutr 37, 887-897.
30. Nève J (1995) Human selenium supplementation as assessed by changes in blood selenium concentration and glutathione peroxidase activity. J Trace Elem Med Biol 9, 65-73.
31. Nève J, Vertongen F & Capel P (1988) Selenium supplementation in healthy Belgian adults: Response in platelet glutathione peroxidase activity and other blood indices. Am J Clin Nutr 48, 139-143.
32. Brown KM, Pickard K, Nicol F, Beckett GJ, Duthie GG & Arthur JR (2000) Effects of organic and inorganic selenium supplementation on selenoenzyme activity in blood lymphoctyes, granulocytes, platelets and erythrocytes. Clin Sci (Lond) 98, 593-599.
33. Bukkens SG, de Vos N, Kok FJ, Schouten EG, de Bruijn AM & Hofman A (1990) Selenium status and cardiovascular risk factors in healthy Dutch subjects. J Am Coll Nutr 9, 128-135.
34. Ravn-Haren G, Olsen A, Tjonneland A, Dragsted LO, Nexo BA, Wallin H, Overvad K, Raaschou-Nielsen O & Vogel U (2006) Associations between GPX1 Pro198Leu polymorphism, erythrocyte GPX activity, alcohol consumption and breast cancer risk in a prospective cohort study. Carcinogenesis 27, 820-825.
35. Tsuchiya Y, Nakajima M, Itoh S, Iwanari M & Yokoi T (2003) Expression of aryl hydrocarbon receptor repressor in normal human tissues and inducibility by polycyclic aromatic hydrocarbons in human tumor-derived cell lines. Toxicol Sci 72, 253-259.
36. Carlsen H, Myhrstad MC, Thoresen M, Moskaug JO & Blomhoff R (2003) Berry intake increases the activity of the γ-glutamylcysteine synthetase promoter in transgenic reporter mice. J Nutr 133, 2137-2140.
37. Whitney AR, Diehn M, Popper SJ, Alizadeh AA, Boldrick JC, Relman DA & Brown PO (2003) Individuality and variation in gene expression patterns in human blood. Proc Natl Acad Sci U S A 100, 1896-1901.
38. Finnstrom N, Thorn M, Loof L & Rane A (2001) Independent patterns of cytochrome P450 gene expression in liver and blood in patients with suspected liver disease. Eur J Clin Pharmacol 57, 403-409.
39. Raucy JL, Schultz ED, Wester MR, Arora S, Johnston DE, Omdahl JL & Carpenter SP (1997) Human lymphocyte cytochrome P450 2E1, a putative marker for alcohol-mediated changes in hepatic chlorzoxazone activity. Drug Metab Dispos 25, 1429-1435.